Testing cerebrolysin with standard care for basilar artery stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding cerebrolysin (a medication that may help repair brain cells) to the usual treatment improves recovery after a stroke in the basilar artery, which supplies the back of the brain. It is meant for people who have had this type of stroke and are otherwise fairly independent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a stroke caused by a blockage in the basilar artery (confirmed by imaging).
- Before the stroke, you were able to live independently or with minor help (score of 0-3 on the modified Rankin Scale).
- You are willing to sign a consent form.
- You are not allergic to any ingredient in the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a clot-busting medicine (tenecteplase) can help people with a specific type of stroke caused by a basilar artery blockage, even if treatment starts later than usual. It aims to improve brain recovery and function by reopening the blocked artery.
This trial tests if endovascular therapy (a procedure to remove a clot) can help people who have had a stroke in the back part of the brain (basilar artery) and can be treated within 72 hours, even if they are not eligible for clot-dissolving medicine. The treatment may improve recovery compared to standard care alone.
This trial tests a procedure to remove a clot in a major artery in the back of the brain (basilar artery) in patients who have had a large stroke there within the past 24 hours. It aims to see if opening the blocked artery can improve recovery.
This trial tests if a procedure to remove a blood clot from the main artery in the back of the brain (basilar artery) can help people who have a large stroke. The procedure is done within 24 hours of symptom onset, and researchers want to see if it can reduce disability.
This trial tests whether a minimally invasive procedure to remove a blood clot from the basilar artery in the back of the brain is safe and effective for people with mild to moderate stroke symptoms. It may be an option if you have a confirmed blockage and can be treated within 24 hours of stroke onset.
This trial tests if a clot-busting drug called Tenecteplase helps people with a severe type of stroke in the back of the brain (basilar artery occlusion) when given 4.5 to 24 hours after symptoms start. Patients will then be moved to a hospital that can remove the clot. The goal is to see if the drug improves recovery.
Hear when a new Basilar Artery Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.